Advertisement

Topics

Carlsberg Group Sets Out Plan to Combat Irresponsible Drinking

04:30 EDT 31 Jul 2017 | 3blmedia - Health

SOURCE: Carlsberg Group

DESCRIPTION:

Beer can be enjoyed at many positive occasions, bringing people together. 

However, irresponsible drinking can turn those positive moments into problematic ones, which is why the Carlsberg Group’s vision for a better tomorrow is a society without irresponsible drinking. No drinking and driving. No underage drinking. Just moderate consumption and enjoyment.

In this area, Carlsberg focuses on choice and collaboration: providing options that help consumers make informed and responsible choices, and collaboration with partners who can help address and prevent alcohol-related harm.

Towards 2030, Carlsberg targets 100% of its markets to improve on responsible drinking every year, and by 2022, targets 100% availability of alcohol-free beer and 100% of packaging and brand activations to include responsible drinking messages.

Carlsberg Group targets

2030

  • 100% of markets improve on responsible drinking year on year

2022

  • 100% availability of alcohol-free beer (AFB) 
  • 100% responsible drinking messaging through packaging and brand activations
  • 100% of markets run partnerships to support responsible consumption

The targets are part of the Carlsberg Group’s new sustainability programme, Together Towards ZERO – which states the brewer’s ambitions and targets towards 2022 and 2030.

Read more about Together Towards ZERO, here.

Tweet me: .@CarlsbergGroup has an ambition of ZERO irresponsible drinking. Learn more: http://bit.ly/2tTBuoZ #TowardsZERO

KEYWORDS: Responsible Production & Consumption, Health & Healthcare, responsible drinking, Carlsberg Group

Original Article: Carlsberg Group Sets Out Plan to Combat Irresponsible Drinking

NEXT ARTICLE

More From BioPortfolio on "Carlsberg Group Sets Out Plan to Combat Irresponsible Drinking"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.